当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
标题(英文)
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
条件
Ann Arbor Stage II Follicular Lymphoma|Ann Arbor Stage III Follicular Lymphoma|Ann Arbor Stage IV Follicular Lymphoma|Grade 1 Follicular Lymphoma|Grade 2 Follicular Lymphoma|Grade 3a Follicular Lymphoma
干预
Drug: Ibrutinib|Biological: Obinutuzumab|Drug: Venetoclax